4. Yip D, Ahmad A, Karapetis CS, Hawkins CA, Harper PG. Matrix metalloproteinase inhibitors: applications in oncology. Invest New Drugs. 1999. 17:387–399.
5. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis. 1992. 10:145–155.
Article
6. Iwata H, Kobayashi S, Iwase H, Masaoka A, Fujimoto N, Okada Y. Production of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human breast carcinomas. Jpn J Cancer Res. 1996. 87:602–611.
Article
7. Kim KW. Tumor metastasis and angiogenesis. J Life Sci. 1994. 4:19–29.
8. Okegawa T, Pong RC, Li Y, Hsieh JT. The role of cell adhesion molecule in cancer progression and its application in cancer therapy. Acta Biochim Pol. 2004. 51:445–457.
Article
9. Sin DI, Park JB, Park KK, Cho CH, Oh HK, Choi CH, Cho HJ, Jang YC. Inhibitory effects of type IV collagenase by disulfiram. J Life Sci. 2006. 16:964–971.
Article
11. The Merck Index. Sulfur. 2001. 13th ed. Merck & Co., INC.
12. Parcell S. Sulfur in human nutrition and applications in medicine. Altern Med Rev. 2002. 7:22–44.
13. Ingenbleek Y. The nutritional relationship linking sulfur to nitrogen in living organisms. J Nutr. 2006. 136:1641S–1651S.
Article
14. Michels FG, Smith JT. A comparison of the utilization of organic and inorganic sulfur by the rat. J Nutr. 1965. 87:217–220.
Article
15. Sasse CE, Baker DH. Sulfur utilization by the chick with emphasis on the effect of inorganic sulfate on the cystine-methionine interrelationship. J Nutr. 1974. 104:244–251.
Article
16. Pappa A, Franco R, Schoneveld O, Galanis A, Sandaltzopoulos R, Panayiotidis MI. Sulfur-containing compounds in protecting against oxidant-mediated lung diseases. Curr Med Chem. 2007. 14:2590–2596.
Article
17. Gamet-Payrastre L, Li P, Lumeau S, Cassar G, Dupont MA, Chevolleau S, Gasc N, Tulliez J, Tercé F. Sulforaphane, a naturally occurring isothiocyanate, induces cell cycle arrest and apoptosis in HT29 human colon cancer cells. Cancer Res. 2000. 60:1426–1433.
18. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis. 2004. 25:83–90.
Article
19. Kim EJ, Kang IJ, Cho HJ, Kim WK, Ha YL, Park JH. Conjugated linoleic acid down regulates insulin-like growth factor-1 receptor levels in HT-29 human colon cancer cells. J Nutr. 2003. 133:2675–2681.
Article
20. Soel SM, Choi OS, Bang MH, Yoon Park JH, Kim WK. Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells
in vitro and
in vivo. J Nutr Biochem. 2007. 18:650–657.
Article
21. Lee HS, Seo EY, Kang NE, Kim WK. [6]-Gingerol inhibits metastasis of MDA-MB-231 human breast cancer cells. J Nutr Biochem. 2008. 19:313–319.
Article
22. Na MH, Seo EY, Kim WK. Effects of α-lipoic acid on cell proliferation and apoptosis in MDA-MB-231 human breast cells. Nutr Res Pract. 2009. 3:265–271.
Article
23. Wu X, Zhu Y, Yan H, Liu B, Li Y, Zhou Q, Xu K. Isothiocyanates induce oxidative stress and suppress the metastasis potential of human non-small cell lung cancer cells. BMC Cancer. 2010. 10:269.
Article
24. Ho CC, Lai KC, Hsu SC, Kuo CL, Ma CY, Lin ML, Yang JS, Chung JG. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways. Hum Exp Toxicol. 2011. 30:296–306.
Article
25. Hwang ES, Lee HJ. Allyl isothiocyanate and its N-acetylcysteine conjugate suppress metastasis via inhibition of invasion, migration, and matrix metalloproteinase-2/-9 activities in SK-Hep 1 human hepatoma cells. Exp Biol Med (Maywood). 2006. 231:421–430.
Article
26. Folkman J, Haudenschild C. Angiogenesis in vitro. Nature. 1980. 288:551–556.
Article
27. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 1991. 5:2145–2154.
Article
28. Werb Z, Vu TH, Rinkenberger JL, Coussens LM. Matrix-degrading proteases and angiogenesis during development and tumor formation. APMIS. 1999. 107:11–18.
Article
29. Murphy G, Reynolds JJ, Hembry RM. Metalloproteinases and cancer invasion and metastasis. Int J Cancer. 1989. 44:757–760.
30. Kawamoto T, Sato JD, Le A, Polikoff J, Sato GH, Mendelsohn J. Growth stimulation of A431 cells by epidermal growth factor: identification of high-affinity receptors for epidermal growth factor by an anti-receptor monoclonal antibody. Proc Natl Acad Sci U S A. 1983. 80:1337–1341.
Article
31. Ura H, Bonfil RD, Reich R, Reddel R, Pfeifer A, Harris CC, Klein-Szanto AJ. Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. Cancer Res. 1989. 49:4615–4621.
32. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res. 1991. 51:5054s–5059s.
33. Tryggvason K, Höyhtyä M, Pyke C. Type IV collagenases in invasive tumors. Breast Cancer Res Treat. 1993. 24:209–218.
Article
34. Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 1993. 53:5365–5369.